CIK 0001761612 · Non-accelerated filer<br>Smaller reporting company
BICYCLE THERAPEUTICS PLC
Sign in to watch- Ticker
- BCYC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 011441223261503
- Business address
- BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
- Former names
- BICYCLE THERAPEUTICS Ltd
- 8-K Event Material agreement · Unregistered share sale · Other events
- F-6EF Other F-6EF
- 8-K Event Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Director acquired 24,000 shares (grant or award)
- SC 13D Stake Beneficial Ownership Report
- 3 Insider Initial Statement of Ownership
- DEFA14A Proxy Proxy Materials
- 8-K Event Material agreement · Executive or director change
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale CHIEF PROD & SUPPLY CHAIN OFF sold 257 shares at $22.49 ($5,780)
- 144 Insider Sale of Securities
- 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 3,158 shares at $23.81 ($75,192)
- 4 Open-market sale CHIEF TECHNOLOGY OFFICER sold 955 shares at $23.81 ($22,739)
- 4 Open-market sale CHIEF OPERATING OFFICER sold 955 shares at $23.81 ($22,739)
- 4 Open-market sale CHIEF BUSINESS OFFICER sold 955 shares at $23.81 ($22,739)
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 790 shares at $23.81 ($18,810)
- 4 Open-market sale CHIEF ACCOUNTING OFFICER sold 152 shares at $23.81 ($3,619)
Page 13 of 33 · 660 filings